6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
44m ago	SCENTRE GROUP ANNOUNCES EXPIRATION AND RESULTS OF TENDER OFFER
45m ago	Pershing Square Holdings, Ltd. ("PSH") Notes the Closing of Initial Public Offering of Pershing Square USA, Ltd. ("PSUS") with Aggregate Offering Size of $5 Billion
45m ago	Viking Named to TIME’s List of the Most Influential Companies
45m ago	Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
1h ago	Mountain Province Diamonds Announces First Quarter 2026 Production and Sales Results, Details of First Quarter 2026 Earnings Release, and Conference Call and board change

About

Urogen Pharma Ltd (NASDAQ:URGN) — investor relations, events, news, and company updates on 6ix.

Latest News

UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer

Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI

UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence

UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results

UroGen Announces Refinanced Term Loan Agreement with Pharmakon Advisors

Financials

Revenue

$109.79 M

Market Cap

$916.2 M

EPS

-3.19

Community Chat

Ask AI